Abstract View

Author(s): Ibrahim Mohammed Ibrahim Elsayed11, Abdulrahman A. M. Bashir12, Qutoof Hashim Taha13, Salah Marajan24, Danya. H. Taha2*5

Email(s): 1daniataha78@gmail.com

Address:

    1. Faculty of Medical Laboratory Science, The National University, Khartoum, Sudan. 2. Faculty of Pharmacy, Sudan University of Science and Technology, Khartoum, Sudan.

Published In:   Volume - 5,      Issue - 6,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5610  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Background: Typhoid fever and malaria remain among the most prevalent infectious diseases in developing countries, contributing to significant morbidity and mortality. Pro-inflammatory cytokines such as interleukin-6 (IL-6) and interleukin-8 (IL-8) play a critical role in the immune response to these infections. While elevated levels of these cytokines are associated with immune clearance, their dysregulation has also been implicated in severe disease outcomes. This study aimed to investigate the levels of IL-6 and IL-8 among typhoid patients co-infected with Plasmodium falciparum in Khartoum State, Sudan. Materials and Methods: A total of 140 blood samples were collected from typhoid patients, malaria patients, co-infected individuals, and healthy controls. Blood films and immunochromatographic tests were used to confirm malaria, while culture and Widal tests were employed to diagnose typhoid. Plasma cytokine levels were measured using a sandwich ELISA. Data were statistically analyzed using chi-square and t-tests. Results: IL-6 levels were significantly higher in typhoid (133.3 pg/mL) and malaria patients (107 pg/mL) compared to healthy controls (37.6 pg/mL). In contrast, co-infected patients had significantly lower IL-6 levels (17.02 pg/mL) than controls (p < 0.0064). Similarly, IL-8 levels were significantly elevated in typhoid (165±7.1 pg/mL) and malaria (184±5.1 pg/mL) patients compared to controls (17±5.9 pg/mL). However, IL-8 levels in co-infected patients (15±7.1 pg/mL) showed a non-significant decline (p = 0.861). Conclusion: The findings suggest that co-infection with P. falciparum may downregulate the pro-inflammatory cytokine response typically observed in mono-infections. This immune modulation could affect clinical outcomes and diagnostic markers. Further studies are recommended to explore the underlying mechanisms of cytokine regulation in co-infections.

Cite this article:
Ibrahim Mohammed Ibrahim Elsayed, Abdulrahman A. M. Bashir, Qutoof Hashim Taha, Salah Marajan, Danya. H. Taha. Analysis of Pro-Inflammatory Cytokines Response Among Typhoid Patients Co-Infection with Plasmodium falciparum In Khartoum State -Sudan. IJRPAS, June 2026; 5(6): 119-125.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5610


References not available.

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags